Timofey Petrov appointed Director General of Innotech

25 October 2021

Moscow, October 25, 2021 – Russian pharmaceutical company NovaMedica announces appointment of Timofey PETROV as the head of the R&D Center NovaMedica Innotech (subsidiary of NovaMedica).

Timofey has been working in the pharmaceutical industry for more than 20 years, and for 15 of them was employed at management positions in development and pharmaceutical production at such manufacturing companies as Rapharma JSC, Pharm-Sintez CJSC and Pharmcontract Group of Companies. He graduated from the Academician Pavlov Ryazan Medical University with a degree in Medical Care and from the S.Y. Witte Moscow University, Department of Economics. Timofey has an Executive MBA from the Moscow School of Management Skolkovo.

Elena Litvinova, Director General of NovaMedica:

We are glad to welcome the new leader of NovaMedica Innotech! I am convinced that Timofey Petrov is the right manager to take Innotech to a leading position in the Russian R&D and contract manufacturing market. I wish Timofey and the employees of NovaMedica Innotech to achieve perfect understanding and work as a well-knit team to meet new and interesting challenges”.

Timofey Petrov, Director General of the R&D Center NovaMedica Innotech:

”I am grateful to the management and shareholders of NovaMedica for having confidence in me, and I will try to justify it through new achievements of NovaMedica Innotech in research and manufacturing. A huge amount of work has been done in the four years since the creation of Innotech. I see the strategy of our further development in increasing the company’s competitiveness in the market by expanding the portfolio of technologies, which we are able to handle. I am sure that together with the professional team of Innotech we will be successful!”

NovaMedica Innotech is a 100% subsidiary of NovaMedica, a project of Rusnano, a Skolkovo resident, a rapidly developing Russian pharmaceutical R&D center opened in April 2017 at Technopolis Moscow. NovaMedica Innotech specializes in development, introduction and manufacturing of innovative, competitive and effective drug products.


Our news

All news

Media Center

Read more